Sociologist Nikolas Rose is interested in how genomics affects personal identity and the social and legal ramifications of studying the human genome. He is the James Martin White Professor of Sociology and the Director of the BIOS Centre for the Study of Bioscience, Biomedicine, Biotechnology and Society at the London School of Economics.

Leslie Vosshall is a molecular neurobiologist who studies how behaviors emerge from the integration of sensory input with internal physiological states. She is the Robin Chemers Neustein Professor, Head of the Laboratory of Neurogenetics and Behavior, and Director of the Kavli Neural Systems Institute at The Rockefeller University.

Freeman Dyson, born and raised in England, excelled in all subjects from a very young age, going on to specialize in mathematics and theoretical physics in his studies at the University of Cambridge.

Oliver Medvedik earned his Ph.D. at Harvard Medical School, in the Biomedical and Biological Sciences program. As part of his doctoral work he has used single-celled budding yeast as a model system to map the genetic pathways that underlie the processes of aging in more complex organisms, such as humans.

Ellen Jorgensen is a molecular biologist and a passionate advocate of citizen science. Her research interests have encompassed such diverse areas as free radicals in disease, DNA fingerprinting, virus protein structure/function relationships, and cancer biomarkers.

Omid Farokhzad is among the Nano50 winners by NASA Nanotech Briefs, which awards the most innovative people and design ideas that will revolutionize nanotechnology. He was one of 12 people to be recognized among the top innovators in Massachusetts by the Boston Globe.

Peter Staley has been a long-term AIDS and gay rights activist, first as a member of ACT UP New York, then as the founding director of TAG, the Treatment Action Group. He served on the board of the American Foundation for AIDS Research (amfAR) for 13 years.

Sheldon Krimsky is a professor of Urban & Environmental Policy & Planning as well as adjunct professor of Public Health and Community Medicine at Tufts University. From 2012 to 2014, he is also a professor of philosophy at Brooklyn College, CUNY.

Rein Ulijn is the founding director of the Nanoscience Initiative at CUNY’s Advanced Science Research Center. He was previously professor and vice dean of research at the University of Strathclyde in Glasgow, Scotland, where he continues to hold a position.

Doris A. Taylor, Ph.D., FACC, FAHA is the Director, Regenerative Medicine Research, and Director, Center for Cell and Organ Biotechnology at the Texas Heart Institute in Houston.

Matthew R. Willmann is the Director of the Plant Transformation Facility (PTF) at Cornell University. PTF is a service facility that makes transgenic and CRISPR/Cas genome-edited plants (maize, rice, wheat, and apple) for Cornell and external faculty.

Carolyn P. Neuhaus is a Bioethicist at The Hastings Center, an independent bioethics research institute in Garrison, New York. She explores philosophical and ethical questions that arise throughout biomedical research, with an eye toward the wise use of emerging technologies.

William B. Hurlbut is a physician and adjunct professor in the Department of Neurobiology at Stanford University Medical Center. His primary areas of interest involve the ethical issues associated with advancing biomedical technology, the biological basis of moral awareness, and studies in the integration of theology and philosophy of biology.